Stocks › ABBV
AbbVie ABBV
US equityMarket cap rank #28
$291.31 +$3.07 (+1.07%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $291.31 0.00%
Open$282.27
Prev close$288.24
Day range$281.07 – $291.73
Volume5.04M
Market cap$514.92B
P/E (TTM)50.1
Dividend yield2.34%
Analyst view
ConsensusBuy
Analysts23
Average target$312.77+7.4% vs. price
- Buy 87%
- Hold 13%
Low $260.00Now $291.31Avg $312.77High $346.00
Recent rating changes
The last 20 actions on file set price targets from $294.00 to $346.00, averaging $318.80.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 4 Nov 2026 | Freedom Capital Markets | BUY | $315.00 |
| 2 Nov 2026 | CCORF | BUY | $338.00 |
| 2 Nov 2026 | UBS | HOLD | $295.00 |
| 2 Nov 2026 | Morgan Stanley | BUY | $346.00 |
| 2 Nov 2026 | BMO Capital | BUY | $340.00 |
| 2 Nov 2026 | Citi | HOLD | $295.00 |
| 2 Nov 2026 | Goldman Sachs | HOLD | $313.00 |
| 2 Nov 2026 | Leerink Partners | BUY | $325.00 |
| 1 Nov 2026 | Cantor Fitzgerald | BUY | $325.00 |
| 1 Nov 2026 | Guggenheim | BUY | $322.00 |
| 30 Oct 2026 | Wells Fargo | BUY | $340.00 |
| 30 Oct 2026 | UBS | HOLD | $295.00 |
| 30 Oct 2026 | BofA Securities | BUY | $319.00 |
| 30 Oct 2026 | Morgan Stanley | BUY | $346.00 |
| 30 Oct 2026 | Citi | HOLD | $295.00 |
| 30 Oct 2026 | Goldman Sachs | HOLD | $294.00 |
| 30 Oct 2026 | RBC Capital | BUY | $330.00 |
| 29 Oct 2026 | Scotiabank | BUY | $320.00 |
| 26 Oct 2026 | Piper Sandler | BUY | $303.00 |
| 26 Oct 2026 | Scotiabank | BUY | $320.00 |
No comments yet — be the first to weigh in on ABBV.
Sign in to join the discussion.